AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Elephtha 440mg Injection

Prescription Icon
Prescription Required

Marketer

Zydus Cadila

Salt Composition

Trastuzumab (440mg)

Overview Elephtha 440mg Injection

Trastuzumab 440mg injection treats breast and gastric cancers by targeting and eliminating HER2-positive cancer cells. Administration is strictly by a healthcare professional via injection, with dosage and frequency determined by your physician based on individual needs and potentially adjusted over time. Adhere precisely to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be immediately apparent; complete the prescribed course unless otherwise instructed. Common side effects include nausea, headache, skin rash, sleep disturbances, and increased infection risk. This medication can reduce blood cell counts, increasing infection vulnerability, necessitating regular blood tests monitoring blood cell levels, cardiac function, liver health, and uric acid. Report shortness of breath, cough, chills, or limb swelling immediately. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This treatment is contraindicated during pregnancy or breastfeeding; reliable contraception for both partners is crucial throughout the treatment period.

Uses of Elephtha 440mg Injection

Cancers affecting the breast and stomach.

Major Benefits of Elephtha 440mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Elephtha 440mg Injection:

  • Anemia (low number of red blood cells)
  • Chills
  • Common cold
  • Cough
  • Decreased blood cells (red cells, white cells, and platelets)
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Infection
  • Insomnia (difficulty in sleeping)
  • Mucosal inflammation
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Upper respiratory tract infection
  • Weight loss

How to use Elephtha 440mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Elephtha 440mg Injection works:

Elephtha 440mg Injection, a monoclonal antibody of the IgG1 recombinant type, targets HER2 (human epidermal growth factor receptor 2) receptors. These receptors drive excessive growth in breast and gastric cancer cells. The injection neutralizes HER2, leading to cancer cell destruction, and concurrently blocks multiple downstream signaling pathways implicated in cancer development.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Elephtha 440mg Injection and alcohol may result in pronounced somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Elephtha 440mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the known hazards. Physician consultation is mandatory.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Elephtha 440mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Driving ability while using Elephtha 440mg Injection is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

The use of Elephtha 440mg Injection in patients with kidney impairment is likely safe. Existing evidence indicates that dose modification may not be necessary. However, physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Elephtha 440mg Injection to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Elephtha 440mg Injection :

Omit a dose of Elephtha 440mg Injection? Seek medical advice immediately.

Facts to Know About Elephtha 440mg Injection

LabelValue
Chemical Type Monoclonal antibody
Developing Habits No.
Treatment Category Cancer Medications
Behavior Class Monoclonal Antibody HER2/neu (ErbB2) Inhibitor

FAQs on Elephtha 440mg Injection

Elephtha 440mg Injection may cause side effects including sore throat, fever, chills, fatigue, pale skin, nosebleeds, and unusual bleeding or bruising. Other possible side effects are stomach pain, seizures, hallucinations, muscle cramps and spasms, nausea or vomiting, loss of appetite, rapid heartbeat, discolored or decreased urine output, painful urination, and other signs of infection. Contact your doctor immediately if you experience any of these symptoms.
Effective contraception is recommended for women of childbearing age throughout Elephtha 440mg Injection therapy and for seven months afterward. Pregnancy planning may resume seven months post-treatment.
Early-stage breast cancer patients should receive Elephtha 440mg Injection for one year, or until disease recurrence, whichever comes first. Treatment should not exceed one year.
Elephtha 440mg Injection does not require fasting prior to administration. It must be administered by a healthcare professional, under the supervision of a physician experienced in cancer chemotherapy.
Elephtha 440mg Injection is available in two formulations: intravenous infusion and subcutaneous injection. Always verify the product label to ensure correct administration as prescribed. The intravenous formulation is for intravenous use only; it should not be given subcutaneously. Your doctor may change your treatment between intravenous and subcutaneous Elephtha 440mg Injection if clinically appropriate.
Elephtha 440mg Injection, a monoclonal antibody, targets the HER2 protein found on some cancer cells. It inhibits cancer growth by binding to HER2. Consequently, this injection is only effective in patients with HER2-positive cancer and is not indicated for those with HER2-negative cancer.
Using Elephtha 440mg Injection with anthracycline cancer drugs (like doxorubicin) can harm your heart. Therefore, your doctor must assess your heart health before and throughout treatment.
Cardiac evaluations are required at treatment initiation, every three months during treatment, and every six months post-treatment for 24 months following the final Elephtha 440mg Injection. Patients with pre-existing cardiac conditions require evaluations every 12 weeks.
Elephtha 440mg Injection
18,481
MRP 20,372
9% off